Webinar | TiO₂ alternatives for food, pharma, and personal care Register Here

Kinnate Biopharma

Kinnate Biopharma develops precision oncology therapeutics to treat patients with genomically-defined cancers.
2018
11-50
San Diego, California, United States
BiopharmaBiotechnologynologyHealth CareMedicalOncologyPrecision MedicineTherapeutics

Investment Funding

Last Funding Stage

Series C

Total Funding Amount

195.M

Last Funding Amount

98.M

Last Funding Date

26-08-2020

Startup Stage

M&A

Lead Investors

RA Capital Management, OrbiMed, Fidelity, Vida Ventures, Janus Henderson Investors

Revenue

Less than $1M

People

Founders